Double blind randomized clinical trial controlled by placebo with an alpha linoleic acid and prebiotic enriched cookie on risk cardiovascular factor in obese patients;Ensayo clínico aletorizado doble ciego controlado con placebo con una galleta enriquecida en ácido alfa linoleico y prebióticos en el patrón de riesgo cardiovascular de pacientes obesos

Nutricion Hospitalaria

Volumn 26, Issue 4, 2011, Pages 827-833

  de Luis, D A ^a   de la Fuente, B ^a   Izaola, O ^a   Conde, R ^a   Gutierrez S ^b   Morillo, M ^c   Teba Torres, C ^c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b División de Investigación Gullon S A   (Spain)

^c Centro de Automatizacion Robotica y Tecnologias de La Informacion y de La Fabricacion   (Spain)

Author keywords

Acid alpha linolenic; Cardiovascular risk factors; Cookies; FOS; Inulin; Obesity

Indexed keywords

LINOLEIC ACID; LIPID; PREBIOTIC AGENT;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DOUBLE BLIND PROCEDURE; EATING; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SAMPLE SIZE;

ADULT; AGED; ANTHROPOMETRY; CARDIOVASCULAR DISEASES; DIET; DOUBLE-BLIND METHOD; EATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINOLEIC ACID; LIPIDS; MALE; MIDDLE AGED; OBESITY; PREBIOTICS; RISK FACTORS; SAMPLE SIZE;

EID: 79960662342     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2011.26.4.5143     Document Type: Article

References (31)

1. Aranceta-Bartrina J, Serra-Majem L, Foz-Sala M, Moreno-Esteban B; Grupo Colaborativo SEEDO. Prevalence of obesity in Spain. Med Clin (Barc) 2005; 125 (12): 460-6.
2. De Luis DA, Aller R, González Sagrado M, Izaola O, Conde R. The effects of a low fat versus a low carbohydrate diet on adipocytokines in obese adults. Hormone Research 2007; 67: 296-300.
3. De Luis DA, Pacheco D, Izaola O, Teroba M, Cuellar L, Martin T. Clinical Results and nutritional consequences of biliopancreatic diversion: Three years of follow up. Ann Nutr Metab 2008; 53: 234-238.
4. Romero AL, Romero JE. Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesteronemic men from northern mexico. J of American College of Nutrition 1998; 6: 601-608.
5. Kerkhoffs D, Hornstra G. Cholesterol-lowering effect of beta glucan from oat bran in mildly hypercholeteronemic subjects may decrease when beta glucan s incorporated into bread and cookies. Am J Clin Nutr 2003; 78: 221-227.
6. Keogh G, Cooper G, Mulvey T. Randomized controlled crossover study of the effect of a highly beta glucan enriched barley on cardiovascular disease risk factors in moldly hypercholesterolemic men. Am J Clin Nutr 2003; 78: 711-718.
7. Roberfroid M. Prebiotics: the concept revisited. 1. J Nutr 2007; 137: 830S-837S.
8. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double blind, placebo controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarctation: the indian experiment of infarct survival 4. Cardiovascular Drugs Ther 1997: 11: 485-491.
9. Freese R, Mutanen M, Valsta SM, Salminen I. Comparison of the effects of two diets rich in monounsaturated fatty acid differing in their linoleic/alpha-linolenic acid ratio on patelet aggregation. Thromb Haemost 1994: 71: 73-77.
10. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher Df. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-414.
11. Lukaski H, Johson PE. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810-7.
12. Mataix J, Mañas M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003.
13. Van Dokkum W, Wezendonk B, Srikumar TS, Van den Heuvel EG. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 1999; 53: 1-7.
14. Letexier D, Diraison F, Beylot M. Addition of inulin 19. To a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin Nutr 2003; 77: 559-564.
15. Balcazar-Munoz BR, Martinez-Abundis E, Gonzalez-Ortiz M. Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia. Rev Med Chil 2003; 131: 597-604.
16. De Luis DA, De la Fuente B, Izaola O, Conde R, Gutiérrez S, Morillo M, Teba Torres C. Ensayo clínico aleatorizado con una galleta enriquecida en insulina en el patrón de riesgo cardiovascular de pacientes obesos. Nutr Hosp 2010; 25: 53-59.
17. Malkki Y. Oat fiber. In Handbook of dietary fiber. Edited bu: Cha SS, Dreher ML, New Cork Macrel Dekker 2001; 497-512.
18. Wolever TMS, Brighenti F, Jenkins DJA. Serum short Chain fatty acids alter rectal infusion of acetate and propionate in man. J Clin Nutr Gastroenterol 1988; 3: 42-46.
19. Rallidis LS, Paschos G, Liakos GK. Dietary alpha linolenic acid decreases c reactive protein, serum amyloid A and interleukin in dyslipemic patients. Atherosclerosis 2003; 167: 237-242.
20. Thies F, Miles EA, Nebe van Caron G. Influence of dietary supplementation with long chain n3 or n6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001; 36: 1183-1193.
21. Vuksan V, Whitham D, Sievenpiper J, Jenkins A, Rogovik A, Bazinet R, Vidgen E, Hanna A. Supplementation of conventional therapy with the novel grain salba (Salvia hispanica L.) Improves major and emerging cardiovascular risk factors in type 2 diabetes. Diabetes Acre 2007; 30: 2804-2810.
22. Bemelmand WJ, Lefrandt JD, Feskens EJ, Van Haeslt PL, Broer J, Meyboom de Jong B, May JF, Tervaert JW. Increased alpha linolenic acid intake lowers C reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr 2004; 58: 1083-1089.
23. Satoh N, Shimatsu A, Kotani K, Sakane N, Yamada K, Suganami T, Kuzuya H, Ogawa Y. Purified eicosapentaenoic acid reduces small dense LDL, remmant lipoprotein particles, and c reactive protein in metabolic syndrome. Diabetes Care 2007; 30: 144-146.
24. Wendland E, Farmer A, Glasziou P, Neil A. Effect of alpha linolenic acid on cardiovascular risk markers:a systematic review. Heart 2006; 92: 166-169.
25. De Lorgeril M, Salen P, Martin JL. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarctation: final report of the Lyon diet heart study. Circulation 1999; 99: 779-785.
26. Burdge GC, Woolton SA. Conversion of alpha linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002; 88: 411-420.
27. Singh RB, Dubnov G, Niaz MA. Effect of an Indo-mediterranean diet on progression of coronary artery disease in high risk patients (INDO Mediterranean Diet heart Study): a randomized single blind trial. Lancet 2002; 360: 1455-1461.
28. López Román J, Martínez Gonzálvez AB, Luque A, Pons Miñano JA, Vargas Acosta A, Iglesias JR, Hernández M, Villegas JA. [The effect of a fibre enriched dietary milk product in chronic primary idiopatic constipation]. Nutr Hosp 2008; 23: 12-9.
29. García Peris P, Velasco Gimeno C. [Evolution in the knowledge on fiber] Nutr Hosp 2007; 22 (Suppl. 2): 20-5.
30. Lecumberri E, Mateos R, Ramos S, Alía M, Rúperez P, Goya L, Izquierdo-Pulido M, Bravo L. [Characterization of cocoa fiber and its effect on the antioxidant capacity of serum in rats] Nutr Hosp 2006; 21: 622-625.
31. Martín de Santa Olalla L, Sánchez Muniz FJ, Vaquero MP. N-3 fatty acids in glucose metabolism and insulin sensitivity. Nutr Hosp 2009; 24: 113-27.